Free Trial

Roivant Sciences (ROIV) Short Interest Ratio & Short Volume

Roivant Sciences logo
$39.53 -0.46 (-1.15%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$39.68 +0.16 (+0.39%)
As of 11/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Roivant Sciences Short Interest Overview

As of October 30, 2026, Roivant Sciences (ROIV) had a short interest of 45.51 million shares sold short, representing 6.91% of the public float. This marks a 12.93% increase in short interest since the prior report. The short interest ratio (days to cover) is 6.1, meaning it would take 6.1 days of the average trading volume of 8.50 million shares to cover all short positions.

Current Short Interest
45,513,591 shares
Previous Short Interest
40,302,998 shares
Change Vs. Previous Report
12.93%
Dollar Volume Sold Short
$1.68 billion
Short Interest Ratio
6.1 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
722,320,000 shares
Short Percent of Float
6.91%
Today's Trading Volume
7,194,652 shares
Average Trading Volume
8,500,850 shares
Today's Volume Vs. Average
85%
Short Selling Roivant Sciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Roivant Sciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ROIV Short Interest Over Time

ROIV Days to Cover Over Time

ROIV Percentage of Float Shorted Over Time

Roivant Sciences Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/202645,513,591 shares $1.68 billion +12.9%6.9%6.07 $36.91
10/15/202640,302,998 shares $1.37 billion +2.6%6.1%7.89 $34.04
9/30/202639,296,630 shares $1.44 billion +8.6%6.0%4.43 $36.57
9/15/202636,181,548 shares $1.43 billion +7.9%5.5%4.13 $39.50
8/31/202633,522,300 shares $1.16 billion +9.5%5.1%3.83 $34.64
8/14/202630,601,726 shares $1.11 billion -13.2%4.6%5.01 $36.20
7/31/202635,233,818 shares $1.19 billion -4.0%5.4%7.99 $33.91
7/15/202636,695,558 shares $1.28 billion +10.5%5.7%7.65 $34.89
6/30/202633,212,917 shares $1.18 billion -0.1%5.2%4.27 $35.39
6/15/202633,244,439 shares $998.33 million -8.3%5.2%7.52 $30.03
5/29/202636,233,835 shares $1.09 billion +32.4%5.6%4.14 $29.99
5/15/202627,377,524 shares $801.89 million +1.2%4.3%5.69 $29.29
4/30/202627,055,375 shares $771.89 million +10.6%4.2%4.83 $28.53
4/15/202624,470,022 shares $719.17 million -1.7%3.8%5.79 $29.39
3/31/202624,884,496 shares $689.65 million +6.4%3.9%4.3 $27.71
3/13/202623,387,772 shares $656.26 million -0.3%3.7%3.63 $28.06
2/27/202623,457,731 shares $678.87 million +5.4%3.7%5.1 $28.94
2/13/202622,266,323 shares $588.94 million -4.4%3.5%2.43 $26.45
1/30/202623,288,019 shares $503.49 million -5.1%3.8%5.08 $21.62
1/15/202624,529,353 shares $571.53 million +25.3%4.0%3.67 $23.30
12/31/202519,579,958 shares $424.89 million +11.8%3.2%2.46 $21.70
12/15/202517,520,355 shares $383.70 million -16.2%2.8%2.21 $21.90
11/28/202520,914,523 shares $435.34 million -9.3%3.4%3.67 $20.82
11/14/202523,049,893 shares $467.68 million -6.0%3.7%2.41 $20.29
10/31/202524,528,207 shares $490.32 million -2.9%4.0%2.78 $19.99
10/15/202525,270,000 shares $429.34 million -9.7%6.1%3.6 $16.99
9/30/202527,970,000 shares $423.19 million -22.8%6.7%4.3 $15.13
9/15/202536,210,000 shares $505.13 million -7.3%8.7%5.4 $13.95
8/31/202539,050,000 shares $465.87 million +2.5%9.0%6.5 $11.93
8/15/202538,090,000 shares $451.37 million -0.6%8.9%6.6 $11.85
7/31/202538,310,000 shares $435.20 million -9.6%9.6%6.7 $11.36
7/15/202542,360,000 shares $481.21 million +3.1%10.6%6.9 $11.36
6/30/202541,100,000 shares $463.20 million -8.8%10.2%6.3 $11.27
6/15/202545,060,000 shares $510.08 million +1.4%10.8%7 $11.32
5/31/202544,430,000 shares $487.84 million -9.8%10.6%6.7 $10.98
5/15/202549,230,000 shares $529.71 million -6.7%11.2%7.6 $10.76
4/30/202552,740,000 shares $612.84 million +3.0%12.0%8 $11.62
4/15/202551,230,000 shares $515.37 million +13.6%11.7%8.5 $10.06
3/31/202545,100,000 shares $455.06 million -13.4%10.3%7.7 $10.09
3/15/202552,090,000 shares $555.28 million +12.9%11.9%9.8 $10.66
Every Starlink dish pays this stock (Ad)

There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel

Claim your free stock pick before December 8th
2/28/202546,140,000 shares $495.54 million +8.8%10.4%10 $10.74
2/15/202542,400,000 shares $447.74 million +0.5%9.6%9.2 $10.56
1/31/202542,200,000 shares $469.69 million -6.0%9.4%8.8 $11.13
1/15/202544,880,000 shares $496.82 million +3.2%10.0%9.6 $11.07
12/31/202443,500,000 shares $514.61 million -1.6%11.5%9.4 $11.83
12/15/202444,200,000 shares $523.33 million -7.6%11.8%8.7 $11.84
11/30/202447,810,000 shares $607.67 million +10.3%12.6%8 $12.71
11/15/202443,350,000 shares $485.52 million -6.9%11.5%6.9 $11.20
10/31/202446,570,000 shares $537.88 million -7.2%12.4%8 $11.55
10/15/202450,190,000 shares $596.26 million -2.0%13.3%8.5 $11.88
9/30/202451,220,000 shares $591.08 million +52.6%13.6%8.3 $11.54
9/15/202433,570,000 shares $400.83 million -12.2%9.0%5.5 $11.94
8/31/202438,220,000 shares $467.43 million -6.6%8.6%7.7 $12.23
8/15/202440,900,000 shares $462.58 million -1.7%9.2%8.2 $11.31
7/31/202441,600,000 shares $451.36 million +1.8%9.3%8.5 $10.85
7/15/202440,850,000 shares $469.78 million -8.7%8.4%8.4 $11.50
6/30/202444,760,000 shares $473.11 million +11.7%8.8%9.2 $10.57
6/15/202440,070,000 shares $428.35 million +8.3%7.9%5.9 $10.69
5/31/202437,000,000 shares $383.32 million -5.0%7.3%5.5 $10.36
5/15/202438,930,000 shares $447.70 million -14.6%7.0%6 $11.50
4/30/202445,580,000 shares $496.82 million +1.0%8.3%6.6 $10.90
4/15/202445,130,000 shares $489.21 million +45.9%8.2%6.2 $10.84
3/31/202430,930,000 shares $326.00 million -2.0%5.6%4.2 $10.54
3/15/202431,570,000 shares $320.12 million +14.0%6.6%5.9 $10.14
2/29/202427,690,000 shares $316.77 million -3.8%5.8%5.1 $11.44
2/15/202428,770,000 shares $329.42 million +11.9%6.0%5.3 $11.45
1/31/202425,710,000 shares $257.10 million -19.6%5.4%4.8 $10.00
1/15/202431,990,000 shares $353.81 million +2.9%5.8%5.4 $11.06
12/31/202331,080,000 shares $349.03 million +9.3%5.7%5.3 $11.23
12/15/202328,440,000 shares $317.39 million -6.6%5.2%4.1 $11.16
11/30/202330,440,000 shares $291.01 million +1.9%5.6%4.6 $9.56
11/15/202329,870,000 shares $270.92 million -10.1%5.5%4.6 $9.07
10/31/202333,230,000 shares $287.11 million -6.3%6.2%5.2 $8.64
10/15/202335,460,000 shares $357.44 million +10.9%6.7%6.3 $10.08
9/30/202331,990,000 shares $373.64 million +74.4%6.1%6 $11.68
9/15/202318,340,000 shares $207.06 million -13.5%3.6%3.7 $11.29
8/31/202321,190,000 shares $245.17 million +3.9%4.9%4.2 $11.57
8/15/202320,390,000 shares $223.68 million -3.4%4.7%4.1 $10.97
7/31/202321,100,000 shares $252.78 million +0.8%4.9%4.5 $11.98
7/15/202320,940,000 shares $244.37 million -9.0%4.8%4.5 $11.67
6/30/202323,000,000 shares $231.84 million +42.5%5.3%5.2 $10.08
6/15/202316,140,000 shares $160.11 million +14.0%3.9%4.2 $9.92
5/31/202314,160,000 shares $128.71 million -1.6%3.4%4.4 $9.09
5/15/202314,390,000 shares $131.67 million +2.6%3.5%4.8 $9.15
4/30/202314,020,000 shares $119.87 million -4.1%3.4%4.8 $8.55
4/15/202314,620,000 shares $103.95 million +5.3%3.6%5 $7.11
3/31/202313,880,000 shares $102.43 million +32.8%3.4%5.1 $7.38
3/15/202310,450,000 shares $89.77 million -1.7%2.6%3.7 $8.59
2/28/202310,630,000 shares $86.00 million -0.5%2.7%4.4 $8.09
2/15/202310,680,000 shares $95.05 million -16.8%2.8%4.4 $8.90
The warning signs most investors see too late (Ad)

Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.tc pixel

Watch Dr Weiss's free video warning before conditions worsen further
1/31/202312,830,000 shares $106.49 million -26.4%3.5%5.5 $8.30
1/15/202317,420,000 shares $171.94 million +6.2%4.8%7.9 $9.87
12/30/202216,400,000 shares $131.04 million +15.7%4.5%8.2 $7.99
12/15/202214,180,000 shares $102.66 million +12.5%3.9%8.4 $7.24
11/30/202212,610,000 shares $67.59 million +2.6%3.6%8.8 $5.36
11/15/202212,290,000 shares $68.09 million -0.2%3.5%10.4 $5.54
10/31/202212,310,000 shares $63.27 million +5.4%3.6%11 $5.14
10/15/202211,680,000 shares $53.49 million +3.6%3.4%13 $4.58
9/30/202211,270,000 shares $36.29 million +8.3%3.3%12.9 $3.22
9/15/202210,410,000 shares $36.44 million +4.5%3.1%11.9 $3.50
8/31/20229,960,000 shares $35.46 million +6.5%2.9%11 $3.56
8/15/20229,350,000 shares $39.74 million +9.2%2.8%8.9 $4.25
7/31/20228,560,000 shares $34.07 million +5.0%2.5%8.5 $3.98
7/15/20228,150,000 shares $34.80 million +24.8%2.4%8.6 $4.27
6/30/20226,530,000 shares $26.58 million +9.8%2.0%7.1 $4.07
6/15/20225,950,000 shares $23.98 million +65.3%1.8%7.4 $4.03
5/31/20223,600,000 shares $15.98 million +60.0%1.1%5.1 $4.44
5/15/20222,250,000 shares $7.79 million -1.3%0.7%4.6 $3.46
4/30/20222,280,000 shares $8.41 million -4.2%0.7%5.8 $3.69
4/15/20222,380,000 shares $9.64 million -18.2%0.7%5.9 $4.05
3/31/20222,910,000 shares $14.38 million +3.2%0.9%7.7 $4.94
3/15/20222,820,000 shares $14.64 million -4.4%0.9%6.9 $5.19
2/28/20222,950,000 shares $18.56 million +0.7%0.9%5.1 $6.29
2/15/20222,930,000 shares $21.15 million +7.3%0.9%4.2 $7.22
1/31/20222,730,000 shares $18.24 million +4.2%0.8%3.7 $6.68
1/15/20222,620,000 shares $20.83 million +12.5%0.8%3.4 $7.95
12/31/20212,330,000 shares $23.49 million No Change0.7%3 $10.08

ROIV Short Interest - Frequently Asked Questions

Short interest is the volume of Roivant Sciences shares that have been sold short but have not yet been closed out or covered. As of October 30th, traders have sold 45,513,591 shares of ROIV short. 6.91% of Roivant Sciences' shares are currently sold short. Learn More on Roivant Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ROIV shares currently have a short interest ratio of 6.1. Learn More on Roivant Sciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.91% of Roivant Sciences' floating shares are currently sold short.

Roivant Sciences saw an increase in short interest since the prior report. As of October 30th, there was short interest totaling 45,513,591 shares, an increase of 12.9% from the previous total of 40,302,998 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.91% of Roivant Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Roivant Sciences: Regeneron Pharmaceuticals, Inc. (2.30%), Moderna, Inc. (9.32%), Natera, Inc. (4.44%), argenex SE (2.30%), Revolution Medicines, Inc. (6.54%), Biogen Inc. (3.70%), Genmab A/S Sponsored ADR (1.57%), Alnylam Pharmaceuticals, Inc. (4.12%), United Therapeutics Corporation (4.72%), Incyte Corporation (6.23%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling ROIV is an investing strategy that aims to generate trading profit from Roivant Sciences as its price is falling. ROIV shares are trading down $0.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Roivant Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ROIV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ROIV, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ROIV:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:ROIV is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners